Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene

被引:69
作者
Hwang, PH [1 ]
Yi, HK
Kim, DS
Nam, SY
Kim, JS
Lee, DY
机构
[1] Chonbuk Natl Univ, Sch Med, Dept Pediat, Chonju 561712, Chonbuk, South Korea
[2] Chonbuk Natl Univ, Sch Med, Res Inst Clin Med, Chonju, South Korea
[3] Chonbuk Natl Univ, Sch Med, Dept Clin Pathol, Chonju, South Korea
[4] Jeonju Univ, Coll Sci & Technol, Dept Biol, Jeonju, South Korea
关键词
PTEN/MMAC1/TEP1; tumorigenicity; metastasis; B16F10; cells;
D O I
10.1016/S0304-3835(01)00632-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PTEN/MMAC1/TEP1 (PTEN) is a tumor suppressor gene that is mutated in a variety of advanced and metastatic cancers, strongly suggests that PTEN alteration is possibly involved in the tumor progression and formation of metastases. However, the roles of PTEN in tumor growth and metastasis and its functional mechanisms are not fully understood. We evaluated the tumor suppressor function of PTEN gene on tumor growth and metastasis in vitro and in vivo. Our results of in vitro soft agar assay and in vivo PTEN-expressing tumor cell growth showed that PTEN inhibited the tumorigenicity of B16F10 melanoma cells. Anti-metastatic function of PTEN was also revealed by experimental pulmonary metastatic animal model. For the further insight into the mechanisms underlying the PTEN-mediated inhibition of tumor metastasis, we have examined the role of PTEN on the secretion of matrix metalloproteinases (MMPs), insulin-like growth factors (IGFs) and the expression of secretory and cellular vascular endothelial growth factor (VEGF) proteins that have been described to contribute to the metastasis of tumor. PTEN significantly lowered MMPs and IGFs secretion and also expression of secretory and cellular VEGF proteins. These results suggest that PTEN tumor suppressor protein inhibits tumorigenicity and metastasis through regulation of MMP, IGFs, and VEGF expression. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:83 / 91
页数:9
相关论文
共 30 条
[21]   Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J].
Steck, PA ;
Pershouse, MA ;
Jasser, SA ;
Yung, WKA ;
Lin, H ;
Ligon, AH ;
Langford, LA ;
Baumgard, ML ;
Hattier, T ;
Davis, T ;
Frye, C ;
Hu, R ;
Swedlund, B ;
Teng, DHF ;
Tavtigian, SV .
NATURE GENETICS, 1997, 15 (04) :356-362
[22]   Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN [J].
Tamura, M ;
Gu, JG ;
Matsumoto, K ;
Aota, S ;
Parsons, R ;
Yamada, KM .
SCIENCE, 1998, 280 (5369) :1614-1617
[23]   PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway [J].
Tamura, M ;
Gu, JG ;
Danen, EHJ ;
Takino, T ;
Miyamoto, S ;
Yamada, KM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) :20693-20703
[24]  
Tamura M, 1999, CANCER RES, V59, P442
[25]  
Tashiro H, 1997, CANCER RES, V57, P3935
[26]  
Teng DHF, 1997, CANCER RES, V57, P5221
[27]   From form to function: Signaling by protein tyrosine phosphatases [J].
Tonks, NK ;
Neel, BG .
CELL, 1996, 87 (03) :365-368
[28]   RELEASE OF AN INHIBITOR OF ANGIOGENESIS UPON INDUCTION OF WILD-TYPE P53 EXPRESSION IN GLIOBLASTOMA CELLS [J].
VAN MEIR, EG ;
POLVERINI, PJ ;
CHAZIN, VR ;
HUANG, HJS ;
DETRIBOLET, N ;
CAVENEE, WK .
NATURE GENETICS, 1994, 8 (02) :171-176
[29]  
Wang SI, 1997, CANCER RES, V57, P4183
[30]   WILD-TYPE P53 INDUCES APOPTOSIS OF MYELOID LEUKEMIC-CELLS THAT IS INHIBITED BY INTERLEUKIN-6 [J].
YONISHROUACH, E ;
RESNITZKY, D ;
LOTEM, J ;
SACHS, L ;
KIMCHI, A ;
OREN, M .
NATURE, 1991, 352 (6333) :345-347